These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14578314)

  • 21. Immune deficiency due to adenosine deaminase and purine nucleoside phosphorylase deficiency: a simple diagnostic test.
    Maddocks JL; Al-Safi SA; Wilson G
    J Clin Pathol; 1984 Nov; 37(11):1305-7. PubMed ID: 6438186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
    Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Leukemia; 1992 May; 6(5):375-80. PubMed ID: 1593902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.
    Hershfield MS; Kredich NM; Ownby DR; Ownby H; Buckley R
    J Clin Invest; 1979 Apr; 63(4):807-11. PubMed ID: 312296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
    Donofrio J; Coleman MS; Hutton JJ; Daoud A; Lampkin B; Dyminski J
    J Clin Invest; 1978 Oct; 62(4):884-7. PubMed ID: 308954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
    Mitchell BS; Kelley WN
    Ann Intern Med; 1980 Jun; 92(6):826-31. PubMed ID: 6247948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of S-adenosylhomocysteine hydrolase in Italy.
    Corbo RM; Palmarino R; Schiattarella E; Giannini MA; Scacchi R
    Hum Hered; 1987; 37(3):186-9. PubMed ID: 3583299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathogenetic significance of adenosine deaminase in autoimmune diseases].
    Sasaki S
    Nihon Seikeigeka Gakkai Zasshi; 1984 Feb; 58(2):219-30. PubMed ID: 6332160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral lymphocytes from patients with solid tumours.
    Russo M; Giancane R; Apice G; Galanti B
    Br J Cancer; 1981 Feb; 43(2):196-200. PubMed ID: 6781524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
    Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
    J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
    Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.
    Tsuchiya S; Nakae S; Konno T; Tada K
    J Inherit Metab Dis; 1981; 4(4):197-201. PubMed ID: 6796770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an assay method for purine catabolic enzymes in the mouse and its adaptation for use on an autoanalyzer.
    Le Tissier PR; Peters J; Skidmore CJ
    Anal Biochem; 1994 Oct; 222(1):168-75. PubMed ID: 7856844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency.
    Ariga T; Oda N; Sanstisteban I; Arredondo-Vega FX; Shioda M; Ueno H; Terada K; Kobayashi K; Hershfield MS; Sakiyama Y
    J Immunol; 2001 Feb; 166(3):1698-702. PubMed ID: 11160213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
    Markert ML; Hershfield MS; Schiff RI; Buckley RH
    J Clin Immunol; 1987 Sep; 7(5):389-99. PubMed ID: 3116034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child.
    Hirschhorn R; Roegner V; Rubinstein A; Papageorgiou P
    J Clin Invest; 1980 Mar; 65(3):768-71. PubMed ID: 6965496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine and deoxyadenosine metabolism in mammalian lymphocytes.
    Peters GJ; Oosterhof A; Veerkamp JH
    Int J Biochem; 1981; 13(4):445-55. PubMed ID: 6263730
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities.
    Blackburn MR; Aldrich M; Volmer JB; Chen W; Zhong H; Kelly S; Hershfield MS; Datta SK; Kellems RE
    J Biol Chem; 2000 Oct; 275(41):32114-21. PubMed ID: 10908569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Grunebaum E; Cohen A; Roifman CM
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):630-8. PubMed ID: 24113229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.